Principal Financial Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-220
Closed -$5.78K – 2198
2026
Q1
$5.78K Buy
220
+77
+54% +$9.68K ﹤0.01% 2176
2025
Q4
$35.4K Sell
143
-39
-21% -$8.9K ﹤0.01% 2165
2025
Q3
$38.3K Buy
182
+13
+8% +$2.29K ﹤0.01% 2223
2025
Q2
$16.6K Buy
+169
New +$14.7K ﹤0.01% 2218
2024
Q2
– Sell
-374
Closed -$35.3K – 2404
2024
Q1
$35.3K Sell
374
-58
-13% -$5.11K ﹤0.01% 2364
2023
Q4
$31.5K Buy
432
+13
+3% +$768 ﹤0.01% 2363
2023
Q3
$27.9K Hold
419
– – ﹤0.01% 2387
2023
Q2
$40.2K Buy
419
+155
+59% +$15.4K ﹤0.01% 2373
2023
Q1
$26.6K Sell
264
-18
-6% -$2.76K ﹤0.01% 2411
2022
Q4
$48.9K Buy
282
+57
+25% +$37.5K ﹤0.01% 2367
2022
Q3
$216K Sell
225
-4
-2% -$3.97K ﹤0.01% 2187
2022
Q2
$154K Buy
+229
New +$142K ﹤0.01% 2339
2021
Q4
– Sell
-188
Closed -$189K – 2568
2021
Q3
$189K Sell
188
-30
-14% -$22.1K ﹤0.01% 2439
2021
Q2
$142K Buy
218
+7
+3% +$4.86K ﹤0.01% 2508
2021
Q1
$156K Buy
211
+15
+8% +$12.1K ﹤0.01% 2395
2020
Q4
$151K Buy
196
+28
+17% +$22.1K ﹤0.01% 2330
2020
Q3
$167K Sell
168
-8
-5% -$8.48K ﹤0.01% 2228
2020
Q2
$183K Buy
176
+49
+39% +$49.3K ﹤0.01% 2200
2020
Q1
$103K Buy
+127
New +$133K ﹤0.01% 2116

Other funds holding GOSS

Principal Financial Group's GOSS Position: Q2 2026 in Review

Principal Financial Group sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 220 shares — an estimated $5.78K sold.

Principal Financial Group first reported a position in GOSS in Q1 2020 and held it in 19 quarters. The position peaked at $216K in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Principal Financial Group reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Principal Financial Group sold 220 Gossamer Bio shares in Q2 2026, an estimated $5.78K.
  • Principal Financial Group first reported a position in Gossamer Bio in Q1 2020 and held it in 19 quarters.
  • Principal Financial Group's Gossamer Bio position peaked at $216K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.